Ray Dalio’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-28,537
Closed -$533K 1081
2022
Q1
$533K Buy
+28,537
New +$513K ﹤0.01% 880

Other funds holding OCDX

Ray Dalio's OCDX Position: Q2 2022 in Review

Ray Dalio sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 28,537 shares — an estimated $533K sold.

Ray Dalio first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $533K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Ray Dalio reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Ray Dalio sold 28,537 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $533K.
  • Ray Dalio first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Ray Dalio's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $533K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Bridgewater Associates's 13F filing for Q2 2022, filed 11 Aug 2022.